Literature DB >> 24150902

Genetic attributes of blood-derived subtype-C HIV-1 tat and env in India and neurocognitive function.

Myres W Tilghman1, Jayanta Bhattacharya, Suprit Deshpande, Manisha Ghate, Stephen Espitia, Igor Grant, Thomas D Marcotte, Davey Smith, Sanjay Mehendale.   

Abstract

Genetic elements in HIV-1 subtype B tat and env are associated with neurotoxicity yet less is known about other subtypes. HIV-1 subtype C tat and env sequences were analyzed to determine viral genetic elements associated with neurocognitive impairment in a large Indian cohort. Population-based sequences of HIV-1 tat (exon 1) and env (C2-V3 coding region) were generated from blood plasma of HIV-infected patients in Pune, India. Participants were classified as cognitively normal or impaired based on neuropsychological assessment. Tests for signature residues, positive and negative selection, entropy, and ambiguous bases were performed using tools available through Los Alamos National Laboratory (http://www.hiv.lanl.gov) and Datamonkey (http://www.datamonkey.org). HIV-1 subtype C tat and env sequences were analyzed for 155 and 160 participants, of which 34-36% were impaired. Two signature residues were unique to impaired participants in exon 1 of tat at codons 29 (arginine) and 68 (proline). Positive selection was noted at codon 29 among normal participants and at codon 68 in both groups. The signature at codon 29 was also a signature for low CD4+ (<200 cells/mm(3)) counts but remained associated with impairment after exclusion of those with low CD4+ counts. No unique genetic signatures were noted in env. In conclusion, two signature residues were identified in exon 1 of HIV-1 subtype C tat that were associated with neurocognitive impairment in India and not completely accounted for by HIV disease progression. These signatures support a linkage between diversifying selection in HIV-1 subtype C tat and neurocognitive impairment.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  clade C; impairment; neuropsychological testing; residue; sequence; signature

Mesh:

Substances:

Year:  2013        PMID: 24150902      PMCID: PMC3872113          DOI: 10.1002/jmv.23816

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  32 in total

1.  Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology.

Authors:  Wayne Delport; Art F Y Poon; Simon D W Frost; Sergei L Kosakovsky Pond
Journal:  Bioinformatics       Date:  2010-07-29       Impact factor: 6.937

2.  Datamonkey: rapid detection of selective pressure on individual sites of codon alignments.

Authors:  Sergei L Kosakovsky Pond; Simon D W Frost
Journal:  Bioinformatics       Date:  2005-02-15       Impact factor: 6.937

3.  Phylogenetic analysis of env, gag, and tat genes of HIV type 1 detected among the injecting drug users in West Bengal, India.

Authors:  Ranajoy Mullick; Satarupa Sengupta; Kamalesh Sarkar; M K Saha; Sekhar Chakrabarti
Journal:  AIDS Res Hum Retroviruses       Date:  2006-12       Impact factor: 2.205

Review 4.  Pathways to neuronal injury and apoptosis in HIV-associated dementia.

Authors:  M Kaul; G A Garden; S A Lipton
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

5.  Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy.

Authors:  M C Strain; S Letendre; S K Pillai; T Russell; C C Ignacio; H F Günthard; B Good; D M Smith; S M Wolinsky; M Furtado; J Marquie-Beck; J Durelle; I Grant; D D Richman; T Marcotte; J A McCutchan; R J Ellis; J K Wong
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Neurological manifestations of HIV disease.

Authors:  R S Wadia; S N Pujari; S Kothari; M Udhar; S Kulkarni; S Bhagat; A Nanivadekar
Journal:  J Assoc Physicians India       Date:  2001-03

7.  Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment.

Authors:  George K Hightower; Joseph K Wong; Scott L Letendre; Anya A Umlauf; Ronald J Ellis; Caroline C Ignacio; Robert K Heaton; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; J A McCutchan; Igor Grant; Susan J Little; Douglas D Richman; Sergei L Kosakovsky Pond; Davey M Smith
Journal:  Virology       Date:  2012-09-20       Impact factor: 3.616

8.  Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat.

Authors:  Jun Yong Choi; George K Hightower; Joseph K Wong; Robert Heaton; Steven Woods; Igor Grant; Thomas D Marcotte; Ronald J Ellis; Scott L Letendre; Ann C Collier; Christina M Marra; David B Clifford; Benjamin B Gelman; Justin C McArthur; Susan Morgello; David M Simpson; J Allen McCutchan; Douglas D Richman; Davey M Smith
Journal:  J Neurovirol       Date:  2012-04-13       Impact factor: 2.643

9.  Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif.

Authors:  Mamata Mishra; S Vetrivel; Nagadenahalli B Siddappa; Udaykumar Ranga; Pankaj Seth
Journal:  Ann Neurol       Date:  2008-03       Impact factor: 10.422

10.  Signature pattern analysis: a method for assessing viral sequence relatedness.

Authors:  B Korber; G Myers
Journal:  AIDS Res Hum Retroviruses       Date:  1992-09       Impact factor: 2.205

View more
  2 in total

1.  Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease.

Authors:  Robert H Paul; John A Joska; Carol Woods; Soraya Seedat; Susan Engelbrecht; Jacqueline Hoare; Jodi Heaps; Victor Valcour; Beau Ances; Laurie M Baker; Lauren E Salminen; Dan J Stein
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

2.  HIV-1 subtype C Tat exon-1 amino acid residue 24K is a signature for neurocognitive impairment.

Authors:  Vurayai Ruhanya; Graeme Brendon Jacobs; Robert H Paul; John A Joska; Soraya Seedat; George Nyandoro; Richard H Glashoff; Susan Engelbrecht
Journal:  J Neurovirol       Date:  2022-04-08       Impact factor: 3.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.